Maravai LifeSciences Holdings Inc expected to post earnings of 4  cents a share - Earnings Preview

Maravai Lifesciences Holdings

06/05/2023 03:03

* Maravai LifeSciences Holdings Inc  MRVI.OQ   MRVI.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 8. 
    * The San Diego California-based  company is expected to
report  a
67.4% decrease in revenue to $79.721 million from $244.29
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. The company's guidance on
February 22 2023, for the period ended March 31, was for revenue
between $75.00 million and $80.00 million.
    * ​Refinitiv's mean analyst estimate for Maravai
LifeSciences
Holdings Inc is for earnings of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $22​, above​ its last closing price
of $14.47. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.35        0.34       0.35      Beat    2.4
 Sep. 30 2022  0.33        0.33       0.37      Beat    12.2
 Jun. 30 2022  0.45        0.45       0.54      Beat    18.8​
 Mar. 31 2022  0.44        0.44       0.54      Beat    23
 ​​Dec.        0.38        0.38       0.45      Beat    17.1
 31 2021                                                
 Sep. 30 2021  0.36        0.35       0.44      Beat    24.9​
 Jun. 30 2021  0.32        0.32       0.44      Beat    39
 Mar. 31 2021  0.21        0.21       0.26      Beat    26.6
 This summary was machine generated May 6 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated